SARS-CoV-2-specific immune response and the pathogenesis of COVID-19

E Gusev, A Sarapultsev, L Solomatina… - International journal of …, 2022 - mdpi.com
… of coronavirus disease (COVID-19) causative agent, severe acute respiratory syndrome
coronavirus 2 (SARS-CoV… , long-term complications of COVID-19. The invasion stage entails the …

SARS-CoV-2/COVID-19: viral genomics, epidemiology, vaccines, and therapeutic interventions

M Uddin, F Mustafa, TA Rizvi, T Loney, H Al Suwaidi… - Viruses, 2020 - mdpi.com
… The COVID-19 pandemic is due to infection caused by the novel SARS-CoV-2 virus that …
respiratory symptoms to the lethal form of COVID-19 which is associated with severe pneumonia…

Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak

M Dai, D Liu, M Liu, F Zhou, G Li, Z Chen, Z Zhang… - Cancer discovery, 2020 - AACR
… of diverse cohorts of patients with cancer affected by COVID-19 is needed. We performed a
… patients confirmed with COVID-19. Our results showed COVID-19 patients with cancer had …

[HTML][HTML] Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies

SF Ahmed, AA Quadeer, MR McKay - Viruses, 2020 - mdpi.com
… proteins of SARS-CoV and SARS-CoV-2, we attempted to leverage immunological studies
of the structural proteins of SARS-CoV to potentially aid vaccine development for SARS-CoV-…

[HTML][HTML] SARSCoV‐2, the virus that causes COVID19: cytometry and the new challenge for global health

…, C Mussini, Modena Covid19 Working Group - Cytometry, 2020 - ncbi.nlm.nih.gov
… of Covid19, similar to what was described in the case of SARS? Can the immaturity of the
immune system protect against immune‐mediated damages that could occur during Covid19

SARS-CoV-2 and COVID-19: The most important research questions

KS Yuen, ZW Ye, SY Fung, CP Chan, DY Jin - Cell & bioscience, 2020 - Springer
… Several interesting papers on SARS-CoV-2 and COVID-19 … of SARS-CoV-2 as well as clinical
characteristics of COVID-19 [… prevention and control of SARS-CoV-2 and COVID-19, in this …

Similarity in case fatality rates (CFR) of COVID-19/SARS-COV-2 in Italy and China

R Porcheddu, C Serra, D Kelvin, N Kelvin… - The Journal of Infection in …, 2020 - jidc.org
… Travel-related cases were the main source of COVID-19 … As of 28 February 2020, twenty-one
cases of COVID-19 have … to improve their chances of survival from COVID-19 disease. …

[HTML][HTML] Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants

MT ul Qamar, SM Alqahtani, MA Alamri… - Journal of pharmaceutical …, 2020 - Elsevier
coronavirus disease 2019 (COVID-19) caused by SARS-CoV-… pro ) enzyme controls
coronavirus replication and is essential … SARS-CoV-2 3CL pro and to discover potent anti-COVID-19

Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience

C Bryce, Z Grimes, E Pujadas, S Ahuja, MB Beasley… - Modern …, 2021 - nature.com
… 100 COVID-19-… COVID-19 cohort disclose elevated inflammatory markers, abnormal
coagulation values, and elevated cytokines IL-6, IL-8, and TNFα. Our autopsy series of COVID-19-…

Antibody responses to SARS-CoV-2 in patients with COVID-19

QX Long, BZ Liu, HJ Deng, GC Wu, K Deng, YK Chen… - Nature medicine, 2020 - nature.com
… Overall, 70.7% (29/41) of the patients with COVID-19 met the criteria of IgG … with COVID-19,
we screened 52 suspected cases in patients who displayed symptoms of COVID-19 or …